[go: up one dir, main page]

NO932842L - 1,4-benzodioksanderivater - Google Patents

1,4-benzodioksanderivater

Info

Publication number
NO932842L
NO932842L NO932842A NO932842A NO932842L NO 932842 L NO932842 L NO 932842L NO 932842 A NO932842 A NO 932842A NO 932842 A NO932842 A NO 932842A NO 932842 L NO932842 L NO 932842L
Authority
NO
Norway
Prior art keywords
benzodioksanderivater
Prior art date
Application number
NO932842A
Other languages
Norwegian (no)
Other versions
NO932842D0 (en
Inventor
Henning Boettcher
Christoph Seyfried
Hartmut Greiner
Gerd Bartoszyk
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO932842D0 publication Critical patent/NO932842D0/en
Publication of NO932842L publication Critical patent/NO932842L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO932842A 1992-08-11 1993-08-10 1,4-benzodioksanderivater NO932842L (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4226527A DE4226527A1 (en) 1992-08-11 1992-08-11 1,4-benzodioxane derivatives

Publications (2)

Publication Number Publication Date
NO932842D0 NO932842D0 (en) 1993-08-10
NO932842L true NO932842L (en) 1994-02-14

Family

ID=6465290

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932842A NO932842L (en) 1992-08-11 1993-08-10 1,4-benzodioksanderivater

Country Status (13)

Country Link
EP (1) EP0586866A3 (en)
JP (1) JPH06184140A (en)
KR (1) KR940003953A (en)
CN (1) CN1085217A (en)
AU (1) AU4456293A (en)
CA (1) CA2103601A1 (en)
CZ (1) CZ159893A3 (en)
DE (1) DE4226527A1 (en)
HU (1) HU9302314D0 (en)
MX (1) MX9304820A (en)
NO (1) NO932842L (en)
PL (1) PL300016A1 (en)
SK (1) SK77693A3 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2595965B2 (en) * 1987-05-11 1997-04-02 株式会社日立製作所 Broadcast communication system
DE69524528T2 (en) * 1994-10-14 2002-08-01 Merck Patent Gmbh CNS active (R) - (-) - 2- [5- (4-fluorophenyl) -3-pyridylmethylaminomethyl] chroman
TW446706B (en) * 1995-02-07 2001-07-21 Janssen Pharmaceutica Nv Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines, a pharmaceutical composition containing them, their intermediates and a process for their preparation
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
AU1504599A (en) * 1997-12-17 1999-07-05 Shionogi & Co., Ltd. Novel pyridine compounds
UA73981C2 (en) 2000-03-10 2005-10-17 Merck Patent Gmbh (r)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chromane for treatment of extrapyramidal movement disorders (variants), pharmaceutical composition and kit
DE10029371A1 (en) * 2000-06-20 2002-01-03 Merck Patent Gmbh Heterocyclic aminoalkylpyridine derivatives as psychotropic drugs
ATE352302T1 (en) 2001-07-26 2007-02-15 Merck Patent Gmbh USE OF 2- 5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL CHROMANE AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS
CN102675302B (en) * 2011-03-17 2014-06-11 南京大学 Thiadiazole derivative containing 1,4-benzdioxanand preparation method and antibacterial activity thereof
CN102690261B (en) * 2011-03-25 2015-02-25 南京大学 Preparation method of 1,4-benzodioxan-containing 1,3,4-oxadiazole derivatives and use of the 1,4-benzdioxan-containing 1,3,4-oxadiazole derivatives in anti-cancer drugs
CN103420989B (en) * 2012-05-15 2016-03-23 华中科技大学 Benzodioxane derivative and application thereof
CN102746286B (en) * 2012-07-25 2015-07-15 山东理工大学 Benzo-dioxazole and preparation method thereof
US9267246B2 (en) 2014-05-20 2016-02-23 Caterpillar Paving Products Inc. Paving machine having vibration-isolated screed assembly

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE613213A (en) * 1961-01-30 1962-07-30 Geigy Ag J R New 1.4-benzodioxanes and their preparation
US3277090A (en) * 1962-07-16 1966-10-04 Frosst & Co Charles E 1:4-benzodioxan derivatives
GB1094982A (en) * 1963-05-08 1967-12-13 Ward Blenkinsop & Co Ltd 1,4-benzodioxanes

Also Published As

Publication number Publication date
EP0586866A3 (en) 1994-04-13
CA2103601A1 (en) 1994-02-12
JPH06184140A (en) 1994-07-05
NO932842D0 (en) 1993-08-10
DE4226527A1 (en) 1994-02-17
AU4456293A (en) 1994-02-17
HU9302314D0 (en) 1993-10-28
PL300016A1 (en) 1994-04-05
KR940003953A (en) 1994-03-14
CZ159893A3 (en) 1994-03-16
EP0586866A2 (en) 1994-03-16
SK77693A3 (en) 1994-05-11
CN1085217A (en) 1994-04-13
MX9304820A (en) 1994-02-28

Similar Documents

Publication Publication Date Title
FI953489A0 (en) 2,6-diaminopuriinijohdannaisia
FI954651A7 (en) Possibly substituted 6,8-quinolines
NO920018D0 (en) 1,3-OKSATIOLANNUKLEOSIDANALOGER
FI923314L (en) SUBSTITUERADE CYCLOPROPYLAMINO-1,3,5-TRIAZINER
FI935260A7 (en) TELEKOMMUNIKATIONSSYSTEM, I VILKET DEBITERINGSDATAN REGISTERRAS I HANDTELEFONEN
FI934610A0 (en) VENTILSAMMANSAETTNING FOER ROERLEDNING, OMFATTANDE LOESTAGBART VENTILSAETE
FI933151L (en) 5,10 METHYLENTETRAHYDROFOLSYRE-CYCLODEXTRIN-INNESLUTNINGSFOERENINGAR
FI930296L (en) 1,4-DISUBSTITUERADE PIPERAZINER
FI932516A7 (en) STYRKONSOL, I SYNNERHET FOER MOTORFORDON
NO932842D0 (en) 1,4-BENZODIOKSANDERIVATER
FI931747L (en) REFLEXKROPP, ISYNNERHET FOER VAEGMARKERINGAR
FI931459L (en) SAMMANSAETTNINGAR MED 1-CHLOR-2,2,2-TRIFLUORETYLDIFLUOR-METHYLETER
DE59308564D1 (en) 2,4-dialkyl-6-sec-alkylphenols
FI932874L (en) 6,7-MODIFIERADE 11B-ARYL-4-ESTRENER
FI923709A0 (en) I EN SAEKERHETSSKENA LAOSBAR VAGN.
FI934928A7 (en) Foerfarande Foer framstaellning av 3,7-dialkylxantiner fraon 3-alkylxantiner
FI932396A7 (en) FOERFARANDE FOER FRAMSTAELLNING AV EN DUBBELSKYDDAD 2,3-HYDROXIMETHYLCYCLOBUTANOL
FI931794L (en) MONOQUATERNAERA 2,16-BISPIPERIDINYLANDROSTANDERS DERIVATIVES
FI931825A7 (en) HYDRAULISK TRYCK- OCH DRAGANORDNING, SPECIEELLT FOER JAERNVAEGSSKENOR
FI930237L (en) FOERFARANDE FOER FRAMSTAELLNING AV 4,6-DIALKOXYPYRIMIDINER
FI934317L (en) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
NO944024D0 (en) 1,2-dihydro-2-oxo-pyridine
NO922732D0 (en) 3,4-DEHYDROPIPERIDINDERIVATER
FI266U1 (en) Kapningsanordning Foer aemnesbana, saosom en pappersbana
FI932595L (en) EN VATTENHALTIG, POLYMERISK, VISCOSITET UPPHOEJANDE KOMPOSITION